Search Results 91-100 of 17365 for Peroxisome
randomization. - Participant has used any peroxisome proliferator-activated receptor (PPAR) ligands such as fibrates and thiazolidinediones within 4 weeks ...
Biomedical engineering and physiology. Clinical and translational science. Immunology. Molecular pharmacology and experimental therapeutics. Neuroscience.
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
The Clinical Core of the Center for Cell Signaling in Gastroenterology supports faculty research by facilitating access to human biospecimens through two ...
The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased brain ...
Effects of peroxisome proliferator-activated receptor-gamma agonists on cognitive function: A systematic review and meta-analysis. Biomedicines. 2023; doi ...
Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging ...
Hypereosinophilic syndrome (HES) is a disorder of certain white blood cells that can cause life-threatening damage to your organs.
Links to Dr. Sierra's research: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and ...
This study is being done to create a "resource" of samples that can be used to improve our ability to diagnose and treat MN, IgAN, MPGN, FSGS/MCD, Lupus ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.